Shenzhen New Industries Biomedical

300832 · SHE · Healthcare / Medical Devices

60.55CNY+1.47 (+2.49%)

Price History

Full chart

Market Stats

Previous Close59.08

Open60.15

Day Range57.80 – 61.50

52-Week Range37.50 – 65.49

Volume6.00M

Market Cap39.58B

P/E (TTM)23.00

Forward P/E0.00

EPS2.19

Dividend Yield2.38%

Beta-0.30

50-Day Avg49.54

200-Day Avg49.80

About

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay analyzers, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

Company Details

SectorHealthcare
IndustryMedical Devices
CEODr. Wei Rao
Employees2.79K
HeadquartersNew Industry Biological Building, Shenzhen, China, 518118, China
Websitehttps://www.snibe.com

Leadership

Dr. Wei RaoChairman of the Board & GM · b. 1964
Ms. Chenliu DingCFO, Accounting Supervisor & Deputy GM · b. 1975
Ms. Haiyan LiuDeputy General Manager · b. 1979
Ms. Lei ZhangSecretary of the Board · b. 1982
Ms. Ting Hua LiDeputy General Manager
Mr. Jinyun YuanDeputy General Manager · b. 1986

Financials

Income Statement

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	258.08M	378.12M	545.28M	731.68M	922.50M	1.14B	1.38B	1.68B	2.19B	2.55B	3.05B	3.93B	4.54B	4.58B
Growth (%)	-	+46.51%	+44.21%	+34.19%	+26.08%	+23.64%	+21.31%	+21.54%	+30.53%	+15.97%	+19.70%	+28.97%	+15.41%	+0.91%
Cost of Revenue	84.71M	104.91M	130.75M	178.09M	195.54M	243.27M	265.48M	337.00M	500.87M	734.30M	906.20M	1.06B	1.27B	1.41B
Gross Profit	173.37M	273.21M	414.52M	553.60M	726.96M	897.29M	1.12B	1.34B	1.69B	1.81B	2.14B	2.87B	3.27B	3.17B
Gross Margin	67.18%	72.25%	76.02%	75.66%	78.80%	78.67%	80.81%	79.96%	77.18%	71.15%	70.26%	72.93%	72.07%	69.25%
Operating Expense	88.64M	112.97M	140.45M	283.76M	226.02M	267.44M	310.36M	445.66M	595.53M	673.68M	637.13M	970.59M	1.16B	1.36B
Operating Income	84.73M	160.24M	274.07M	269.83M	500.94M	629.85M	807.77M	898.92M	1.10B	1.14B	1.50B	1.90B	2.11B	1.81B
Operating Margin	32.83%	42.38%	50.26%	36.88%	54.30%	55.22%	58.38%	53.46%	50.05%	44.69%	49.35%	48.23%	46.55%	39.49%
EBITDA	88.03M	164.59M	278.80M	279.21M	506.69M	633.20M	765.75M	882.47M	1.10B	1.15B	1.44B	1.89B	2.11B	2.06B
EBITDA Margin	34.11%	43.53%	51.13%	38.16%	54.93%	55.52%	55.34%	52.48%	50.20%	45.23%	47.42%	48.05%	46.52%	44.96%
Net Income	75.13M	141.27M	252.87M	249.12M	451.69M	538.21M	694.00M	772.61M	939.15M	973.70M	1.33B	1.65B	1.83B	1.62B
Net Income Margin	29.11%	37.36%	46.38%	34.05%	48.96%	47.19%	50.16%	45.95%	42.79%	38.25%	43.58%	42.08%	40.32%	35.40%
R&D	-	-	22.01M	28.05M	47.17M	57.15M	84.24M	119.59M	150.58M	215.05M	317.71M	366.05M	453.59M	477.77M
R&D as % of Total Revenue	-	-	4.04%	3.83%	5.11%	5.01%	6.09%	7.11%	6.86%	8.45%	10.43%	9.31%	10.00%	10.44%
Interest Expense	69.48K	1.42M	1.29M	359.83K	372.58K	482.78K	1.16M	0	1.15M	1.48M	1.86M	2.60M	2.52M	530.51K
Interest Expense % of Total Revenue	0.03%	0.37%	0.24%	0.05%	0.04%	0.04%	0.08%	0.00%	0.05%	0.06%	0.06%	0.07%	0.06%	0.01%

Balance Sheet

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	313.11M	540.96M	745.44M	1.15B	1.61B	2.02B	2.64B	3.46B	5.31B	6.14B	7.01B	8.22B	9.62B	9.94B
Total Liabilities	64.93M	162.12M	134.92M	124.94M	185.75M	250.00M	274.52M	318.92M	503.96M	523.51M	615.06M	678.09M	1.04B	795.91M
Total Equity	248.18M	378.84M	610.52M	1.02B	1.42B	1.77B	2.37B	3.14B	4.80B	5.61B	6.40B	7.54B	8.58B	9.14B
Cash	160.60M	209.25M	250.54M	506.20M	898.60M	1.08B	1.43B	1.98B	1.07B	617.58M	483.43M	1.05B	919.53M	997.44M
Total Debt	-	51.38M	-	-	-	-	-	-	1.20M	881.00K	893.07K	3.49M	2.76M	-
Net Debt	-160.60M	-157.87M	-250.54M	-506.20M	-898.60M	-1.08B	-1.43B	-1.98B	-1.07B	-616.70M	-482.53M	-1.04B	-916.77M	-

Cash Flow

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	55.80M	138.33M	242.77M	305.93M	486.81M	524.73M	701.97M	831.73M	976.65M	773.22M	962.39M	1.42B	1.36B	1.52B
Investing Cash Flow	-6.56M	-134.69M	-120.98M	-108.62M	-37.32M	-156.33M	-249.57M	-285.46M	-2.49B	-924.57M	-593.72M	-290.73M	-705.15M	-
Financing Cash Flow	19.09M	45.41M	-79.91M	57.60M	-58.44M	-187.17M	-102.37M	-8.31M	653.67M	-287.43M	-497.45M	-568.61M	-790.20M	-
Capital Expenditure	12.30M	142.95M	129.21M	119.50M	56.03M	176.51M	284.87M	327.11M	254.82M	342.94M	403.22M	322.20M	439.20M	311.44M
Free Cash Flow	43.51M	-4.62M	124.26M	186.43M	430.78M	348.22M	417.10M	504.62M	721.84M	430.28M	559.17M	1.10B	917.24M	1.21B
Dividends Paid	9.71M	11.91M	22.59M	42.40M	55.56M	185.20M	101.17M	618.98M	618.98M	412.35M	471.68M	550.00M	785.96M	1.02B
FCF to OCF	77.96%	-3.34%	51.19%	60.94%	88.49%	66.36%	59.42%	60.67%	73.91%	55.65%	58.10%	77.28%	67.62%	79.54%
Dividend Paid to FCF	22.33%	-257.79%	18.18%	22.74%	12.90%	53.18%	24.25%	122.66%	85.75%	95.83%	84.35%	50.18%	85.69%	84.38%

Earnings

Report Date	Aug 21, 2020	Oct 28, 2020	Mar 30, 2021	Apr 26, 2021	Aug 19, 2021	Oct 27, 2021	Mar 31, 2022	Apr 21, 2022	Aug 25, 2022	Oct 20, 2022	Dec 31, 2022	Apr 6, 2023	Aug 24, 2023	Oct 26, 2023	Apr 25, 2024	Aug 23, 2024	Oct 28, 2024	Dec 31, 2024	Apr 25, 2025	Aug 25, 2025	Oct 28, 2025	Dec 31, 2025	Apr 27, 2026	Aug 13, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.60	0.72	0.60	0.60	0.56	0.57	0.57	0.57	0.50
EPS Actual	0.46	0.28	0.58	0.41	0.33	0.30	0.39	0.39	0.33	0.45	0.51	0.51	0.50	0.56	0.59	0.61	0.59	0.50	0.56	0.42	0.55	0.53	0.53	0.55
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.17%	-18.06%	-16.26%	-6.67%	-25.00%	-3.51%	-6.62%	-7.02%	10.00%
Timing	After-hours	Pre-market	Pre-market	After-hours	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	-	Pre-market	After-hours	Pre-market	Pre-market	-	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap39.58B

Enterprise Value36.31B

Trailing P/E23.00

Forward P/E0.00

Price / Sales8.22

Price / Book4.29

EPS2.19

Book Value11.42

Revenue (TTM)4.81B

Gross Profit (TTM)3.39B

EBITDA2.14B

Profit Margin35.68%

Operating Margin36.98%

Return on Equity19.87%

Return on Assets12.99%

Shares Outstanding785.72M

Shares Float329.14M

Beta-0.30

Dividend Yield2.38%

Dividend Rate1.20

Payout Ratio55.59%

Dividends

20261×

1.20May 27, 2026

20251×

1.30May 28, 2025

20241×

1.00May 15, 2024

20231×

0.70Jun 8, 2023

20221×

0.60Jun 23, 2022

20211×

0.53May 21, 2021

20201×

0.79Sep 25, 2020

Stock Splits

May 21, 20211.9:1